Proteins in cancer multidrug resistance
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue
Abstract
Multidrug Resistance (MDR) is defined as insensitivity to administered medicines that are structurally unrelated and have different molecular targets. Cancers possess numerous mechanisms of drug resistance, involving various aspects of cell biology. A pivotal role in this phenomenon is played by proteins – enzymatic or structural parts of the cell.Membrane transporters, including the main members of ABC protein family – P-gp, MRP1 and BCRP, as well as LRP, which builds structure of vaults, determine the multidrug-resistant phenotype by decreasing drug concentration within the cell or modifying its distribution to intracellular compartments. The π isoform of protein enzyme – glutathione S-transferase (GSTP-1), is responsible for excessive intensity of detoxification of cytostatics. A common example of altered drug target site that does not respond to chemotherapy is topoisomerase II α (TopoIIa). Alterations of programmed cell death result from expression of metallothionein (MT) – inhibitor of the process, and cytokeratin 18 (CK18), which, if in high concentration, also prevents apoptosis of cells.Several methods of decreasing activity of these proteins have been developed, aiming to overcome MDR in cancer cells. However, for a variety of reasons, their clinical suitability is still very low, leading to continuous increase in death rate among patients. This paper presents current state of knowledge on the most important examples of proteins responsible for MDR of cancer cells and molecular mechanisms of their action.
Authors and Affiliations
Marta Popęda, Elżbieta Płuciennik, Andrzej K. Bednarek
Keywords
Related Articles
- EP ID EP67382
- DOI -
- Views 157
- Downloads 0
Component-resolved diagnostics of food allergy – do we know more?
Component - resolved diagnostics (CRD) is the research method that allows to determine the concentrations of specific immunoglobulin E against a particular allergenic components. The paper discusses the importance of CRD...
Apoptoza chondrocytów w przebiegu osteoartrozy
Osteoartroza (OA) jest zwyrodnieniową chorobą stawów, w której zaburzona jest równowaga między procesami degradacji a regeneracji chrząstki stawowej, co prowadzi do jej postępującej utraty. Choroba jest najczęściej wystę...
Eksperymentalne modele ostrego zapalenia trzustki
Ostre zapalenie trzustki jest chorobą o ciężkim przebiegu i znacznej śmiertelności. Badania kliniczne mogą dostarczyć danych dotyczących etiologii, patogenezy i przebiegu ostrego zapalenia trzustki. Jednak badania dotycz...
Molekularne mechanizmy regulacji przerzutowania komórek nowotworowych na przykładzie mięsaka prążkowanokomórkowego (rhabdomyosarcoma)
Mięsak prążkowanokomórkowy lub inaczej rhabdomyosarcoma to nowotwór złośliwy tkanek miękkich pochodzący z embrionalnej tkanki mezenchymalnej i neuroektodermalnej. Bardzo często współwystępuje z innymi zespołami genetyczn...
Are KIR genes associated with clinical parameters in the course of periodontitis?
Introduction: Periodontitis is a common chronic inflammatory disease. It seems that natural killer (NK) cells play a role in the pathogenesis of periodontitis. KIRs are a family of inhibitory or activating receptors expr...